FDA Warning Letter Breakdown: Testing the Line Between Consumer Wellness Claims and Regulated Physiologic Measurement Functions in Wearables Gray Market Peptides: So Much Hype, So Little Data BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157: Miracle Healing Peptide or Hidden Danger? FDA and FTC Issue 13 Warning Letters to E liquid Companies for Misleadingly Marketing to Youth; FDA Investigates Underage Use of JUUL Devices The Continuum of Risk